ATE110367T1 - Kalziumantagonisten. - Google Patents
Kalziumantagonisten.Info
- Publication number
- ATE110367T1 ATE110367T1 AT90102575T AT90102575T ATE110367T1 AT E110367 T1 ATE110367 T1 AT E110367T1 AT 90102575 T AT90102575 T AT 90102575T AT 90102575 T AT90102575 T AT 90102575T AT E110367 T1 ATE110367 T1 AT E110367T1
- Authority
- AT
- Austria
- Prior art keywords
- represented
- alkyl
- group
- substituent
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Details Of Resistors (AREA)
- Amplifiers (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30975089A | 1989-02-10 | 1989-02-10 | |
US07/457,997 US5106845A (en) | 1990-01-10 | 1990-01-10 | Calcium antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE110367T1 true ATE110367T1 (de) | 1994-09-15 |
Family
ID=26976983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90102575T ATE110367T1 (de) | 1989-02-10 | 1990-02-09 | Kalziumantagonisten. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0389765B1 (de) |
JP (1) | JP2879918B2 (de) |
KR (1) | KR0149165B1 (de) |
CN (1) | CN1044813A (de) |
AT (1) | ATE110367T1 (de) |
AU (1) | AU621193B2 (de) |
CA (1) | CA2009542C (de) |
DE (1) | DE69011714T2 (de) |
ES (1) | ES2063177T3 (de) |
FI (1) | FI900650A0 (de) |
HU (1) | HU204795B (de) |
NO (1) | NO900646L (de) |
NZ (1) | NZ232396A (de) |
PT (1) | PT93106A (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW245719B (de) * | 1990-09-10 | 1995-04-21 | Sterling Winthrop Inc | |
US5380721A (en) * | 1990-09-10 | 1995-01-10 | Sterling Winthrop Inc. | Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents |
US5314903A (en) * | 1991-12-03 | 1994-05-24 | Neurosearch A/S | Benzimidazole compounds useful as calcium channel blockers |
CA2104060A1 (en) * | 1992-11-10 | 1994-05-11 | Robert Ed Johnson | Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136188A (en) * | 1976-06-25 | 1979-01-23 | Daiichi Seiyaku Co., Ltd. | Treatment of diabetes with 2-substituted-1,3-diazacyclic compounds |
US4093726A (en) * | 1976-12-02 | 1978-06-06 | Abbott Laboratories | N-(2-benzimidazolyl)-piperazines |
US4174401A (en) * | 1977-07-13 | 1979-11-13 | Mcneil Laboratories, Incorporated | 2-Benzhydrylimino-imidazolidines |
US4235894A (en) * | 1979-01-30 | 1980-11-25 | Mcneilab, Inc. | 2-Benzhydrylimino-1,3-diazacarbocyclic compounds, compositions and methods of use |
US4243667A (en) * | 1979-01-30 | 1981-01-06 | Mcneil Laboratories, Incorporated | 2-Benzhydrylimino-1,3-diazacarbocyclic compounds as inhibitors of gastric secretion |
US4868181A (en) * | 1986-08-04 | 1989-09-19 | E. I. Du Pont De Nemours And Company | 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity |
US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
FR2658823B1 (fr) * | 1990-02-27 | 1992-04-30 | Adir | Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent . |
-
1990
- 1990-02-07 NZ NZ232396A patent/NZ232396A/en unknown
- 1990-02-07 CA CA002009542A patent/CA2009542C/en not_active Expired - Fee Related
- 1990-02-08 HU HU90728A patent/HU204795B/hu not_active IP Right Cessation
- 1990-02-08 KR KR1019900001501A patent/KR0149165B1/ko not_active IP Right Cessation
- 1990-02-09 PT PT93106A patent/PT93106A/pt not_active Application Discontinuation
- 1990-02-09 AU AU49325/90A patent/AU621193B2/en not_active Ceased
- 1990-02-09 AT AT90102575T patent/ATE110367T1/de not_active IP Right Cessation
- 1990-02-09 FI FI900650A patent/FI900650A0/fi not_active Application Discontinuation
- 1990-02-09 EP EP90102575A patent/EP0389765B1/de not_active Expired - Lifetime
- 1990-02-09 DE DE69011714T patent/DE69011714T2/de not_active Expired - Fee Related
- 1990-02-09 ES ES90102575T patent/ES2063177T3/es not_active Expired - Lifetime
- 1990-02-09 NO NO90900646A patent/NO900646L/no unknown
- 1990-02-09 JP JP2031292A patent/JP2879918B2/ja not_active Expired - Fee Related
- 1990-02-10 CN CN90100644A patent/CN1044813A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
HU204795B (en) | 1992-02-28 |
EP0389765B1 (de) | 1994-08-24 |
FI900650A0 (fi) | 1990-02-09 |
ES2063177T3 (es) | 1995-01-01 |
CA2009542C (en) | 2000-03-14 |
AU4932590A (en) | 1990-08-16 |
AU621193B2 (en) | 1992-03-05 |
CN1044813A (zh) | 1990-08-22 |
EP0389765A1 (de) | 1990-10-03 |
NO900646D0 (no) | 1990-02-09 |
KR900012918A (ko) | 1990-09-03 |
DE69011714D1 (de) | 1994-09-29 |
JPH02282368A (ja) | 1990-11-19 |
HUT53089A (en) | 1990-09-28 |
HU900728D0 (en) | 1990-04-28 |
JP2879918B2 (ja) | 1999-04-05 |
KR0149165B1 (ko) | 1998-10-15 |
PT93106A (pt) | 1990-08-31 |
NZ232396A (en) | 1991-07-26 |
CA2009542A1 (en) | 1990-08-10 |
NO900646L (no) | 1990-08-13 |
DE69011714T2 (de) | 1994-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK160877C (da) | Fremgangsmaade til fremstilling af 2-penemforbindelser | |
ES2088076T3 (es) | Piperacinil- y piperidinilciclohexanoles. | |
ATE169008T1 (de) | 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament | |
IL66650A (en) | Dibenzoxepines and dibenzooxazepines,their preparation and pharmaceutical compositions containing them | |
NO892381D0 (no) | 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner. | |
ATE380818T1 (de) | Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose | |
ATE117295T1 (de) | 4-oxochinolin-3-carbonsäure-derivate, ihre herstellung und ihre verwendung. | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
DE69119013D1 (de) | Benzen-, Pyridin-, Pyrimidinderivat | |
ES2111930T3 (es) | Antagonistas del acido amp y procedimientos de tratamiento con la ayuda de estos. | |
ATE95816T1 (de) | 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung. | |
PT74199A (de) | Neue trisubstituierte pyrimido<5,4-d>pyrimidine ihre herstel- lung und ihre verwendung als arzneimittel | |
ATE110367T1 (de) | Kalziumantagonisten. | |
EA200401077A1 (ru) | 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b | |
ES2099180T3 (es) | Derivados del benzopirano y procedimientos para su preparacion. | |
ES2110454T3 (es) | Compuestos de 6-oxo-azepinoindol, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos. | |
SE9904177D0 (sv) | Novel compounds | |
DE69402703D1 (de) | 3-(INDOL-3-YL) PROPENSäURDERIVATE, DIE ALS NMDA- ANTAGONISTEN NÜTZLICH SIND | |
EA199900460A1 (ru) | Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные | |
IE882107L (en) | Pyrimidones | |
ATE28192T1 (de) | 4-alkylimidazol-derivate, ihre herstellung und verwendung. | |
ATE99306T1 (de) | Antagonisten von leukotrien d4. | |
ES497949A0 (es) | Procedimiento para la preparacion de nuevos 4-amino-2,6-dia-riltetrahidrotiopiranos sustituidos | |
TH17166A (th) | ฟีนิลอมิโนซัลโฟนิลยูเรียที่ถูกแทนที่สำหรับฆ่าวัชพืช |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |